Clinical Trial

Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period

Completed
View on ClinicalTrials.gov →
Summary
The primary purpose of the research is to evaluate in healthy adults the time course effects of energy drink formulas containing 120 mg caffeine with varying levels of taurine and b vitamins on subjective alertness in the presence of cognitive load assessed hourly up to 5 hours post dose
Protocol Amendment History 5 changes
critical Trial completed 2026-07-07
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-13
notable Primary completion moved earlier: 2026-08-30 -> 2026-07-15 2026-06-13
minor Completion moved earlier: 2026-08-30 -> 2026-07-15 2026-06-13
critical Primary endpoint(s) modified 2026-04-14
Trial Details
NCT Number NCT07400614
Lead Sponsor PepsiCo Global R&D
Conditions Alertness
Enrollment 48 participants
Start Date 2026-01-26
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-24